ClinicalTrials.Veeva

Menu

Effect of Theronomic Ova-All Care on Biomarkers of Ovarian Health in Adult Female With Polycystic Ovarian Syndrome

W

Wellizen Australia

Status and phase

Not yet enrolling
Phase 2

Conditions

Polycystic Ovarian Syndrome (PCOS)

Treatments

Dietary Supplement: Theronomic Ova-All Care

Study type

Interventional

Funder types

Industry

Identifiers

NCT06963840
WEL202501

Details and patient eligibility

About

Theronomic Ova-All Care is a tribiotic health product aimed at improving ovarian health in people with polycystic ovarian syndrome (PCOS). In this study, a total of 16 participants with PCOS diagnosed by a gynaecologist will be invited to take Ova-All Care, two capsule once a day, for 12 weeks. Biomarkers of ovarian health will be measured at baseline, four weeks after the start of the intervention, and at the end of the intervention.

Enrollment

16 estimated patients

Sex

Female

Ages

18 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria

  1. Women aged 18-40 years
  2. Previous diagnosis of PCOS by a gynaecologist
  3. Able to take body temperature every day for 12 weeks
  4. Able to attend the testing centre every 4 weeks
  5. Able to complete online questionnaires

Exclusion criteria

  1. Pregnancy, lactation;
  2. Uterine amenorrhea (such as intrauterine adhesions)
  3. Thyroid disease or hyperprolactinemia
  4. Liver and kidney dysfunction, autoimmune diseases (such as systemic lupus erythematosus), malignant tumors, mental illness
  5. Use of contraceptives, hormone replacement therapy (HRT), immunosuppressants and other drugs that affect ovarian function in the past 3 months.
  6. Smokers (>5 cigarettes per day), alcoholics;
  7. Unable to cooperate with follow-up or refuse to sign informed consent.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

16 participants in 1 patient group

Theronomic Ova-All Care
Experimental group
Description:
Active treatment - Theronomic Ova-All Care
Treatment:
Dietary Supplement: Theronomic Ova-All Care

Trial contacts and locations

1

Loading...

Central trial contact

Yoann Birling, Doctor of Philosophy

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems